London,UK; This event will provide an overview on the key features and objectives of the EU’s new clinical trial regulation. It will also cover the future clinical trial authorisation process, the functionalities of the EU CT portal and database, transparency aspects of the new regulation, and safety reporting requirements.
Sessions will be presented by European Medicines Agency (EMA) representatives, speakers from national competent authorities and an SME company.
The event is open to companies that have been assigned SME status by the EMA and representatives of stakeholder organisations. A live webcast of the event will also be available for companies wishing to attend remotely.
Further registration details will be provided in due course, once the final agenda is released.